ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: MD Anderson’s Judith Smith Questions NCI Short-Term Remedy For Carboplatin Dosing

October 15, 2010

In Brief: Bristol Has Change Of Heart, Agrees To Supply NCI With VP-16 Free For Group C Distribution

July 16, 1982

Information Lacking On Use, Accuracy Of HER2 Tests

September 25, 2009

BRCA Carriers Live Longer Than Those With Normal Gene

January 25, 2008

NCI Cooperative Group Clinical Trials Approved

December 25, 2009

ACS Research Grants Hit $78.2 Million

July 18, 1986